Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 4/20 | 0.51 |
| ▸ | FURIN | P09958 | 6/20 | 0.49 |
| ▸ | PCSK6 | P29122 | 1/20 | 0.49 |
| ▸ | GNPAT | O15228 | 1/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.43 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.43 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.43 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30625295 | 0.96 | FURIN (0.50) | FOLH1FURINPCSK6GNPATGRIN2D | |
| SCHEMBL31369282 | 0.89 | FOLH1 (0.50) | FOLH1GNPATGRIN2DGRIN3BGRIN1 | |
| SCHEMBL31232452 | 0.89 | FOLH1 (0.47) | FOLH1 | |
| SCHEMBL30194119 | 0.87 | BACE1 (0.47) | FOLH1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL29571467 | 0.87 | BACE1 (0.46) | FOLH1 | |
| SCHEMBL29479874 | 0.86 | GRIN2D (0.55) | FOLH1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL31378167 | 0.86 | GNPAT (0.48) | FOLH1GNPATALDH1A1 | |
| SCHEMBL5354118 | 0.86 | BACE1 (0.46) | FOLH1 | |
| SCHEMBL5354110 | 0.86 | BACE1 (0.46) | FOLH1 | |
| SCHEMBL30570973 | 0.86 | FURIN (0.46) | FOLH1FURINPCSK6GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722714-A1 | SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) | Korea Institute of Science and Technology (KR) | 2026-04-08 | — | — | EP | claimed |
| EP-4722714-A1 | SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) | Korea Institute of Science and Technology (KR) | 2026-04-08 | — | — | EP | disclosed |
| WO-2025262156-A1 | HYDROPHOBIC PHASE COMPOSITION COMPRISING DEHYDRATED LIPOSOMES WITH NUTRITIONAL SUPPLEMENT | MIDRA B.V. (NL) | 2025-12-26 | — | — | WO | disclosed |
| US-20250360156-A1 | SYNERGISTIC COMBINATION OF NAD+ AND THERAPEUTIC PEPTIDES DELIVERED VIA IONTOPHORESIS FOR ENHANCED AND PROLONGED REGENERATIVE EFFECTS | ANDREWS NICHOLAS JEROME (US) | 2025-11-27 | — | — | US | disclosed |
| US-20250205274-A1 | FORMULATIONS FOR TREATMENT OF XEROSTOMIA, AND METHODS THEREFOR | MED1 VENTURES | 2025-06-26 | — | — | US | disclosed |
| WO-2024204211-A1 | METHOD FOR PRODUCING METAL POWDER, AND METAL POWDER | 昭栄化学工業株式会社 | 2024-10-03 | — | — | WO | disclosed |
| US-11981581-B2 | Stannous oxide powder | JX METALS CORPORATION (JP) | 2024-05-14 | — | — | US | disclosed |
| CN-116973466-A | Solid phase extraction-liquid chromatography-mass spectrometry detection method for small peptide substances | 北京体育大学 | 2023-10-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250205274-A1 | FORMULATIONS FOR TREATMENT OF XEROSTOMIA, AND METHODS THEREFOR | MUC1, SIGLEC7, TAS2R38 | FOLH1 2486/4885FURIN 2726/4885PCSK6 3440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.